Skip to content

A randomized, open, blank controlled, single center clinical study of 635 nm low frequency red light in the treatment and control of myopia in children and adolescents

A randomized, open, blank controlled, single center clinical study of 635 nm low frequency red light in the treatment and control of myopia in children and adolescents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048186
Enrollment
Unknown
Registered
2021-07-04
Start date
2021-07-15
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

experimental group:635 nm low frequency red light therapy

Sponsors

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 4 to 18 years, diagnosed with myopia after mydilated optometry; 2. Those who have never done any other measures to prevent myopia; 3. The observation objects are equipped with frame glasses.

Exclusion criteria

Exclusion criteria: 1. Children who have used or are using atropine or orthokeratology for myopia control; 2. Secondary myopia, such as retinopathy of prematurity or other infant eye diseases resulting in secondary myopia, or myopia combined with systemic syndrome, such as Marfan syndrome; 3. People who have undergone intraocular surgery or have undergone eye trauma such as penetration, severe chemical injury, thermal burn, etc.; 4. Bilateral anisometropia greater than 1.00D, or strabismus, amblyopia; 5. Opacity of the refractive medium (such as keratopathy, crystal opacity, etc.); 6. Patients with fundus retinopathy or other intraocular diseases; 7. Patients with optic nerve damage or congenital optic nerve dysfunction; 8. Pathological myopia or hyperactivity disorder; 9. Other reasons that researchers think are not suitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
uncorrected visual acuity;Best corrected visual acuity;Ocular axis;Choroidal thickness;Corneal curvature;Anterior chamber depth;

Countries

China

Contacts

Public ContactQin Qin

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School

qinqin.1219@hotmail.com+86 15005161908

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026